Jürgen Okun Selected Research

PPA protocol

1/2022

Final results of the southwest German pilot study on cystic fibrosis newborn screening - Evaluation of an IRT/PAP protocol with IRT-dependent safety net.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jürgen Okun Research Topics

Disease

2	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 03/2021
2	Chronic Renal Insufficiency 01/2020 - 12/2019
1	Meconium Ileus 01/2022
1	Hypervitaminosis A 03/2021
1	Lung Diseases (Lung Disease) 03/2021
1	Exocrine Pancreatic Insufficiency 03/2021
1	Pneumonia (Pneumonitis) 03/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Obesity 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2019
1	Neoplasms (Cancer) 01/2018
1	Glioma (Gliomas) 08/2014

Drug/Important Bio-Agent (IBA)

2	IndicanIBA 01/2020 - 12/2019
2	VaccinesIBA 01/2018 - 08/2014
1	ivacaftorIBA 03/2021
1	Immunoglobulin G (IgG)IBA 03/2021
1	LipidsIBA 03/2021
1	lumacaftorIBA 03/2021
1	Vitamin A (Retinol)FDA LinkGeneric 03/2021
1	VitaminsIBA 03/2021
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 03/2021
1	Uremic ToxinsIBA 01/2020
1	Sulfates (Sulfates, Inorganic)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 12/2019
1	PolyaminesIBA 01/2018
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 08/2014
1	AntibodiesIBA 08/2014

Therapy/Procedure

1	PPA protocol 01/2022
1	Therapeutics 03/2021